Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Company Announcement: PHILLIP SECURITIES PTE LTD

Singapore, April 20 -- PHILLIP SECURITIES PTE LTD made the following announcement: Security Name: JD HK SDR 10TO1 REPL::Cash Dividend/ Distribution::Mandatory (https://links.sgx.com/1.0.0/corporate-... Read More


Singapore Company Announcement: SEATRIUM LIMITED

Singapore, April 20 -- SEATRIUM LIMITED made the following announcement: Security Name: SEATRIUM LTD WD::Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Cha... Read More


Singapore Company Announcement: MDR LIMITED

Singapore, April 20 -- MDR LIMITED made the following announcement: Security Name: MDR LIMITED General Announcement::Net Tangible Assets ("NTA") Per Share (https://links.sgx.com/1.0.0/corporate-anno... Read More


Singapore Company Announcement: VICOM LTD

Singapore, April 20 -- VICOM LTD made the following announcement: Security Name: VICOM LTD. General Announcement::SUPPLEMENTARY RESPONSES TO QUESTIONS FROM SHAREHOLDERS (https://links.sgx.com/1.0.0/... Read More


Singapore Company Announcement: PSC CORPORATION LTD.

Singapore, April 20 -- PSC CORPORATION LTD. made the following announcement: Security Name: PSC CORPORATION LTD. REPL::Annual General Meeting::Voluntary (https://links.sgx.com/1.0.0/corporate-announ... Read More


Singapore Company Announcement: STATE STREET GLOBAL ADVISORS SINGAPORE LIMITED

Singapore, April 20 -- STATE STREET GLOBAL ADVISORS SINGAPORE LIMITED made the following announcement: Security Name: SS SPDR STI ETF General Announcement::Net Asset Value Per Unit (https://links.sg... Read More